|

Real-world Insight Into Systemic Therapies for HCC: Single-center Study

RECRUITINGSponsored by Mansoura University
Actively Recruiting
SponsorMansoura University
Started2026-08-01
Est. completion2027-12-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07814014

Summary

Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* patient with HCC
* Child-Pugh class A, B7
* Performance state 0-1 (Eastern Cooperative Oncology Group (ECOG scale).
* Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE.

Exclusion Criteria:

* patient with other tumor than HCC
* Child-Turcotte-Pugh score B (8,9) and C.
* Patients eligible for treatment other than systemic therapy according to Barcelona Clinic liver cancer.

Conditions4

CancerHCC - Hepatocellular CarcinomaLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.